<Page>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------------
FORM 8-K/A1
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 3, 2002
---------------
INMEDICA DEVELOPMENT CORPORATION
-----------------------------------------------------------------------
(Exact name of registrant as specified in charter)
Utah 0-12968 87-0397815
-----------------------------------------------------------------------
(State or other juris- (Commission (IRS Employer
diction of incorporation) File Number) Identification No.)
825 N. 300 West, Suite N132
Salt Lake City, Utah 84103
-----------------------------------------------------------------------
(Address of principal executive offices)
Registrant's telephone number, including area code: (801)521-9300
-------------
<Page>
ITEM 4. CHANGES IN REGISTRANT CERTIFIED ACCOUNTANT
On January 3, 2002, InMedica Development Corporation ("the Company")
engaged Deloitte & Touche as independent accountants to audit the Company's
December 31, 2001 financial statements. The former accountants, Arthur Andersen
LLP, were notified of their dismissal on January 4, 2002. The change was
approved by the Company's board of directors.
There have been no disagreements with the former independent
accountants, Arthur Andersen LLP, on any matter of accounting principles,
practice, financial statement disclosure or auditing scope or procedure nor have
there been any reportable events relating to the former accountants' advice. The
former accountants' reports for the last two years have not contained an adverse
opinion or disclaimer of opinion. However the former accountants' reports have
been modified for uncertainty as to whether the registant would continue as a
going concern. There was no qualification or modification as to audit scope or
accounting principles. The updated letter of Arthur Andersen LLP to the
Commission is filed herewith as Exhibit 16.
Item 7. EXHIBITS.
A copy of the former independent accountants' updated letter to the
Commission is filed as Exhibit 16 to this report.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
INMEDICA DEVELOPMENT CORPORATION
(Registrant)
By: /s/ Richard Bruggeman
-------------------------------
Richard Bruggeman, CFO
DATED: January 17, 2002
2
<Page>
EXHIBIT INDEX
INMEDICA DEVELOPMENT CORPORATION - FORM 8-K/A1
Exhibit 16 .........Letter re change in certifying accountant
3